Product Information
TAFLUPROST 0.0015% EYE DROP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $2.5020 per EA under NDC 50742033930. Its NADAC has been published 64 times since Apr 9, 2025.
Strength
.015 mg/mL
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742033930
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
TAFLUPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA218002On Market Since
12/18/2024
Pharmacological Classes
Price Statistics
The NADAC for TAFLUPROST 0.0015% EYE DROP has been published 64 times since Apr 9, 2025, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5020 per EA |
|---|---|
| All-time high | $3.6204 (Apr 16, 2025) |
| All-time low | $2.5020 (Jun 17, 2026) |
| 52-week high | $3.3303 |
| 52-week low | $2.5020 |
| Median price | $3.0157 |
| Average price | $3.0653 |
| Largest weekly change | -7.5% (Jun 17, 2026) |
| Weeks tracked | 64 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TAFLUPROST 0.0015% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TAFLUPROST 0.0015% EYE DROP, manufactured by Ingenus Pharmaceuticals LLC, is $2.5020 per EA (NDC 50742033930), effective Jun 24, 2026.
How has the price of TAFLUPROST 0.0015% EYE DROP changed over time?
Over the history we have for it, the NADAC for TAFLUPROST 0.0015% EYE DROP has declined 30.9%. It has been tracked across 64 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for TAFLUPROST 0.0015% EYE DROP?
Since Apr 9, 2025, the NADAC for TAFLUPROST 0.0015% EYE DROP has ranged from a low of $2.5020 (Jun 17, 2026) to a high of $3.6204 (Apr 16, 2025), with a median of $3.0157 per EA.
Are there cheaper alternatives to TAFLUPROST 0.0015% EYE DROP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TAFLUPROST 0.0015% EYE DROP, but none are currently priced below it.
Who manufactures TAFLUPROST 0.0015% EYE DROP?
TAFLUPROST 0.0015% EYE DROP (NDC 50742033930) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification